Observational study compares effectiveness and adherence in HCV treatment, suggesting the need for targeted support strategies.
SOF/VEL and GLE/PIB demonstrate similarly high effectiveness in routine clinical practice. Adherence is the principal determinant of treatment success, particularly in high-risk populations. Targeted strategies to support adherence are essential to optimizing real-world HCV treatment outcomes.
No takes yet. Share an insight, caveat, or question.
Baker et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: